BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 19046115)

  • 1. Multimodality therapy for the curative treatment of cancer of the esophagus and gastroesophageal junction.
    Ku GY; Ilson DH
    Expert Rev Anticancer Ther; 2008 Dec; 8(12):1953-64. PubMed ID: 19046115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative therapy for esophageal cancer.
    Ku GY; Ilson DH
    Gastroenterol Clin North Am; 2009 Mar; 38(1):135-52, ix. PubMed ID: 19327572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of neoadjuvant therapy for esophageal adenocarcinoma.
    Ku GY; Ilson DH
    Surg Oncol Clin N Am; 2009 Jul; 18(3):533-46. PubMed ID: 19500742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer of the gastroesophageal junction: combined modality therapy.
    Ilson DH
    Surg Oncol Clin N Am; 2006 Oct; 15(4):803-24. PubMed ID: 17030275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II trial of accelerated multimodality therapy for locoregionally advanced cancer of the esophagus and gastroesophageal junction: the impact of clinical heterogeneity.
    Adelstein DJ; Rice TW; Rybicki LA; Saxton JP; Videtic GM; Murthy SC; Zuccaro G; Vargo JJ; Dumot JA; Carroll MA
    Am J Clin Oncol; 2007 Apr; 30(2):172-80. PubMed ID: 17414467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophageal cancer: adjuvant therapy.
    Ku GY; Ilson DH
    Cancer J; 2007; 13(3):162-7. PubMed ID: 17620765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative therapy in esophageal cancer.
    Ku GY; Ilson DH
    Clin Adv Hematol Oncol; 2008 May; 6(5):371-9. PubMed ID: 18516027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative and adjuvant therapies for upper gastrointestinal cancers.
    Varadhachary G; Ajani JA
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):719-25. PubMed ID: 16111471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
    Van Cutsem E; Van de Velde C; Roth A; Lordick F; Köhne CH; Cascinu S; Aapro M;
    Eur J Cancer; 2008 Jan; 44(2):182-94. PubMed ID: 18093827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidisciplinary treatment of advanced cancer of the esophagus and gastroesophageal junction: a European center's approach.
    Lerut T; Moons J; Coosemans W; Decaluwé H; Decker G; De Leyn P; Nafteux P; Van Raemdonck D
    Surg Oncol Clin N Am; 2008 Jul; 17(3):485-502, vii-viii. PubMed ID: 18486879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and therapy in advanced cancer of the esophagus and the gastroesophageal junction.
    Lerut T; Coosemans W; Decker G; De Leyn P; Moons J; Nafteux P; Van Raemdonck D
    Curr Opin Gastroenterol; 2006 Jul; 22(4):437-41. PubMed ID: 16760764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localized adenocarcinoma of the esophagogastric junction--is there a standard of care?
    Power DG; Reynolds JV
    Cancer Treat Rev; 2010 Aug; 36(5):400-9. PubMed ID: 20117883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodality therapy of local regional esophageal cancer.
    Kelsen DP
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S6-10. PubMed ID: 16399422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoradiotherapy for localized esophageal cancer: regimen selection and molecular mechanisms of radiosensitization.
    Kleinberg L; Gibson MK; Forastiere AA
    Nat Clin Pract Oncol; 2007 May; 4(5):282-94. PubMed ID: 17464336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemoradiotherapy for resectable oesophageal and gastro-oesophageal junction cancer--do we need another randomised trial?
    Hingorani M; Crosby T; Maraveyas A; Dixit S; Bateman A; Roy R
    Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):696-705. PubMed ID: 21684129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenocarcinoma of the proximal esophagus: report of 9 patients and review of the literature.
    Marano S; Ruol A; Castoro C; Portale G; Cagol M; Alfieri R; Michieletto S; Ancona E
    Ann Surg Oncol; 2008 Oct; 15(10):2910-4. PubMed ID: 18696159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction.
    Lagarde SM; ten Kate FJ; Reitsma JB; Busch OR; van Lanschot JJ
    J Clin Oncol; 2006 Sep; 24(26):4347-55. PubMed ID: 16963732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant therapy of esophageal carcinoma.
    Reed CE
    Chest Surg Clin N Am; 1994 May; 4(2):299-314. PubMed ID: 8049998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of radiotherapy in the multimodal management of esophageal cancer.
    Fokas E; Weiss C; Rödel C
    Dig Dis; 2013; 31(1):30-7. PubMed ID: 23797120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoradiotherapy for esophageal cancer: current status and perspectives.
    Ohtsu A
    Int J Clin Oncol; 2004 Dec; 9(6):444-50. PubMed ID: 15616874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.